# OnCo record saad-usmani (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/saad-usmani/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "saad-usmani" ;
  schema:name "Saad Z. Usmani"@en ;
  schema:description "Saad Usmani led the pivotal teclistamab study, the first bispecific antibody approved for myeloma."@en ;
  schema:url <https://onco.cc/people/saad-usmani/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/doctors/saad-usmani>, <https://pubmed.ncbi.nlm.nih.gov/?term=Usmani%20SZ%5BAuthor%5D> ;
  schema:jobTitle "Chief, Myeloma Service" ;
  schema:sameAs <https://orcid.org/0000-0002-5484-8731> ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:drugs <https://onco.cc/drugs/teclistamab/>, <https://onco.cc/drugs/daratumumab/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/majestec-1/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .